Gastric Acid Suppression Is Associated With Decreased Erlotinib Efficacy in Non–Small-Cell Lung Cancer

Title
Gastric Acid Suppression Is Associated With Decreased Erlotinib Efficacy in Non–Small-Cell Lung Cancer
Authors
Keywords
Drug interactions, Erlotinib, Histamine type-2 receptor antagonist, Non-small cell lung cancer, Proton pump inhibitors
Journal
Clinical Lung Cancer
Volume 16, Issue 1, Pages 33-39
Publisher
Elsevier BV
Online
2014-08-16
DOI
10.1016/j.cllc.2014.07.005

Ask authors/readers for more resources

Reprint

Contact the author

Find Funding. Review Successful Grants.

Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.

Explore

Discover Peeref hubs

Discuss science. Find collaborators. Network.

Join a conversation